Close Menu

Anaphylaxis to Pegylated Liposomal Doxorubicin: A Case Report

Journal Authors: 
Issue: 
DOI: 
10.7727/wimj.2013.270
Pages: 
376–7
ABSTRACT 
 
Liposomal doxorubicin is used for the treatment of various cancers like epithelial ovarian cancers, multiple myeloma and sarcomas. We report the first case of anaphylaxis to pegylated liposomal doxorubicin.
 
Accepted: 
30 Oct, 2013
PDF Attachment: 
e-Published: 19 May, 2014
Top of Page